Morgan & Morgan Announces the Investigation of Zoltek Companies Inc. ZOLT

NEW YORK, Oct. 3, 2013 /PRNewswire/ -- Morgan & Morgan announces that it is investigating potential legal claims against the board of directors of Zoltek Companies Inc. ("Zoltek") (NASDAQ: ZOLT) regarding possible breaches of fiduciary duties and other violations of law related to the Company's efforts to sell the Company to Toray Industries, Inc. in a cash deal valued at approximately $584 million.

If you purchased Zoltek, and want more information about the Zoltek takeover lawsuit, please contact George Pressly, Esq. at 1(800) 631-6234 or email George at AskGeorge@morgansecuritieslaw.com.

Under the terms of the transaction, Zoltek shareholders will receive $16.75 for each share of Zoltek stock they own. Morgan & Morgan's investigation concerns whether Zoltek's Board of Directors breached its fiduciary duties to act in the best interests of Zoltek shareholders and to take all necessary steps to ensure that Zoltek shareholders receive the maximum value readily available for their shares of Zoltek common stock. 

Morgan & Morgan is one of the nation's largest 200 law firms. In addition to securities fraud, the firm also practices in the areas of antitrust, personal injury, consumer protection, overtime, and product liability.  All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people." 

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:
Morgan & Morgan
Peter Safirstein, Esq.
28 West 44th Street
Suite 2001
New York, NY  10036
1-800-631-6234
info@morgansecuritieslaw.com

SOURCE Morgan & Morgan



RELATED LINKS
http://www.securitieslawfirm.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.